Mankind Pharma, Zydus Lifesciences fuel Nifty Pharma to 52-week high; index trades 9.8% higher YTD
The Nifty Pharma surged to its 52-week high of 25,043.15 points on May 20, after Mankind Pharma and Zydus Lifesciences Q4 results gains and margin expansion supported the sectoral benchmark index.
The Nifty Pharma surged to its 52-week high of 25,043.15 points on May 20, after Mankind Pharma and Zydus Lifesciences Q4 results gains and margin expansion supported the sectoral benchmark index.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
